课题基金 / 基金详情

Evolutionary approaches to treat and evade antibiotic resistant pathogenic bacteria

Evolutionary approaches to treat and evade antibiotic resistant pathogenic bacteria
治疗和逃避抗生素耐药病原菌的进化方法
批准号:
333587
负责人:
Tokuriki Nobuhiko
金额:
$77.07万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-09-01 至 2020-09-01

项目摘要

项目成果

Tokuriki Nobuhiko的其他基金

相关文献

中文摘要
翻译
细菌感染是人类健康的主要威胁。在上个世纪,抗生素已经成为我们对抗细菌感染的武器。然而,不幸的是,细菌已经进化出对几乎所有已知抗生素的抗性,
英文摘要
Bacterial infections are major threats to human health. In the last century, antibiotics have served as our arsenals to fight bacterial infections. However, unfortunately, bacteria have since evolved resistance against virtually all known antibiotics, in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance (DISTOMOS)
  • 批准号:
    487206
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.42万
  • 财政年份:
    2023
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Comprehensive characterizations for the molecular and evolutionary mechanisms of beta-lactam 'resistome'
  • 批准号:
    443847
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2021
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Novel antibiotic therapies that target bacterial energetic systems
  • 批准号:
    433902
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.66万
  • 财政年份:
    2020
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Metallo-beta-lactamases; mechanistic and evolutionary studies.
  • 批准号:
    268768
  • 项目类别:
    Salary Programs
  • 资助金额:
    $21.86万
  • 财政年份:
    2012
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位: